Cracking the code to beat addiction
Lumme is developing a cutting-edge addiction treatment platform by combining wearable technology, machine learning, and behavioral psychology. We are pushing the boundaries of digital health beyond activity monitoring by extracting actionable intelligence to offer deeper insights about health. Our mission is to deliver comprehensive solutions to the 200M individuals in our nation battling addiction with nicotine, alcohol, diet, marijuana, opioid, and other drugs.
Lumme is funded by multiple Small Business Innovation Research grants from the National Cancer Institute and the National Institutes of Alcohol Abuse and Alcoholism. Years of research conducted at UMass Amherst and Yale School of Medicine has gone into designing this treatment platform. Our products are ethically designed to be patient-centric and clinically validated based on FDA guidelines.